Characterization of standard work tools for intrathecal baclofen therapy

Author(s):  
Ajay Patel ◽  
Samuel Stegelmann ◽  
Josue D. Ordaz ◽  
Virendra Desai ◽  
Francisco Angulo-Parker ◽  
...  
2018 ◽  
Vol 5 (3) ◽  
pp. 65-68 ◽  
Author(s):  
Takeshi Hara ◽  
Madoka Nakajima ◽  
Hidenori Sugano ◽  
Kostadin Karagiozov ◽  
Emiko Hirose ◽  
...  

2010 ◽  
Vol 26 (8) ◽  
pp. 1097-1102 ◽  
Author(s):  
Gnanamurthy Sivakumar ◽  
Yoong Yap ◽  
Mekidm Tsegaye ◽  
Michael Vloeberghs

2014 ◽  
Vol 60 (4) ◽  
pp. 295-301
Author(s):  
Alev Cevikol ◽  
Oznur Ecerkale ◽  
Hande Sancioglu ◽  
Mehmet Sorar ◽  
Aytul Cakci

2018 ◽  
Vol 60 (4) ◽  
pp. 367-373 ◽  
Author(s):  
Peck Yee Liew ◽  
Kirsty Stewart ◽  
Debra Khan ◽  
Sarah Jane Arnup ◽  
Adam Scheinberg

2021 ◽  
Vol 1 (1) ◽  
Author(s):  
Takeshi Satow ◽  
Masafumi Ogawa ◽  
Taro Komuro

BACKGROUNDLesch-Nyhan disease (LND) is a very rare metabolic disorder involving the purine salvage pathway. LND manifests hyperuricemia, self-mutilation, cognitive impairment, and movement disorders such as spasticity and dystonia, whose control is difficult pharmaceutically.OBSERVATIONSIntrathecal baclofen (ITB) therapy was received by a 22-year-old male for generalized dystonia. His paroxysmal abnormal dystonic posturing reduced after surgery, making the task of caregivers easier despite the unchanged assignment on the dystonia scale during a follow-up period of 4 years.LESSONSITB may be a safe and feasible option for dystonic symptoms and difficulty with nursing care in patients with LND.


Sign in / Sign up

Export Citation Format

Share Document